[go: up one dir, main page]

NO993717L - Anvendelse av gastrointestinale lipase-inhibitorer - Google Patents

Anvendelse av gastrointestinale lipase-inhibitorer

Info

Publication number
NO993717L
NO993717L NO993717A NO993717A NO993717L NO 993717 L NO993717 L NO 993717L NO 993717 A NO993717 A NO 993717A NO 993717 A NO993717 A NO 993717A NO 993717 L NO993717 L NO 993717L
Authority
NO
Norway
Prior art keywords
lipase inhibitors
gastrointestinal lipase
gastrointestinal
inhibitors
lipase
Prior art date
Application number
NO993717A
Other languages
English (en)
Other versions
NO324452B1 (no
NO993717D0 (no
Inventor
Jonathan Brian Hauptman
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO993717(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO993717D0 publication Critical patent/NO993717D0/no
Publication of NO993717L publication Critical patent/NO993717L/no
Publication of NO324452B1 publication Critical patent/NO324452B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
NO19993717A 1997-02-05 1999-07-30 Anvendelse av tetrahydrolipstatin til fremstilling av medikamenter mot diabetes NO324452B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05
PCT/EP1998/000468 WO1998034630A1 (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Publications (3)

Publication Number Publication Date
NO993717D0 NO993717D0 (no) 1999-07-30
NO993717L true NO993717L (no) 1999-10-04
NO324452B1 NO324452B1 (no) 2007-10-22

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993717A NO324452B1 (no) 1997-02-05 1999-07-30 Anvendelse av tetrahydrolipstatin til fremstilling av medikamenter mot diabetes

Country Status (28)

Country Link
US (1) US6147108A (no)
EP (1) EP1017408B1 (no)
JP (1) JP2001509173A (no)
KR (1) KR100479968B1 (no)
CN (1) CN1154505C (no)
AR (1) AR011106A1 (no)
AT (1) ATE292975T1 (no)
AU (1) AU740375B2 (no)
BR (1) BR9807655A (no)
CA (1) CA2278854C (no)
CZ (1) CZ295567B6 (no)
DE (1) DE69829763T2 (no)
DK (1) DK1017408T3 (no)
ES (1) ES2239799T3 (no)
HK (1) HK1025251A1 (no)
HU (1) HU230834B1 (no)
ID (1) ID22650A (no)
IL (1) IL131007A0 (no)
ME (1) ME00578A (no)
NO (1) NO324452B1 (no)
NZ (1) NZ336755A (no)
PL (1) PL191222B1 (no)
PT (1) PT1017408E (no)
RU (1) RU2201272C2 (no)
TR (1) TR199901853T2 (no)
WO (1) WO1998034630A1 (no)
YU (1) YU34199A (no)
ZA (1) ZA98753B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL191222B1 (pl) * 1997-02-05 2006-03-31 Hoffmann La Roche Zastosowanie tetrahydrolipstatyny do wytwarzania doustnego farmaceutycznego preparatu do leczenia cukrzycy typu II
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
ATE428733T1 (de) 2000-03-14 2009-05-15 Unilever Nv Variabele domänen der schweren kette eines antikörpers gegen menschliche ernährungslipasen und deren verwendungen
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
WO2006014673A2 (en) 2004-07-19 2006-02-09 Nobex Corporation Insulin-oligomer conjugates, formulations and uses thereof
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US7254429B2 (en) * 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
CA2604653A1 (en) 2005-04-13 2006-10-19 Glucolight Corporation Method for data reduction and calibration of an oct-based blood glucose monitor
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
EP2036575B1 (en) * 2007-09-12 2010-08-18 Mader S.r.l. Pharmaceutical compositions for oral use for treating patients affected by obesity
US20100317642A1 (en) * 2007-10-15 2010-12-16 Inventis Dds Pvt Limited Pharmaceutical composition of orlistat
CA2702892C (en) 2007-10-16 2017-02-28 Biocon Limited An orally administerable solid pharmaceutical composition and a process thereof
US8768423B2 (en) 2008-03-04 2014-07-01 Glt Acquisition Corp. Multispot monitoring for use in optical coherence tomography
WO2010042499A1 (en) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
CN109414414A (zh) 2016-03-16 2019-03-01 戴维·格拉德斯通研究所 用于治疗肥胖症和/或糖尿病以及用于鉴定候选治疗剂的方法和组合物
US20190022061A1 (en) * 2017-07-21 2019-01-24 Kieu Hoang Statins (Atorvastatin) can lower blood sugar level in diabetic

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
PL191222B1 (pl) * 1997-02-05 2006-03-31 Hoffmann La Roche Zastosowanie tetrahydrolipstatyny do wytwarzania doustnego farmaceutycznego preparatu do leczenia cukrzycy typu II

Also Published As

Publication number Publication date
AR011106A1 (es) 2000-08-02
CN1246798A (zh) 2000-03-08
CZ265199A3 (cs) 2000-02-16
NZ336755A (en) 2001-06-29
YU34199A (sh) 2002-08-12
CA2278854C (en) 2014-03-04
HU230834B1 (hu) 2018-07-30
DK1017408T3 (da) 2005-08-01
TR199901853T2 (xx) 1999-12-21
AU740375B2 (en) 2001-11-01
PL334975A1 (en) 2000-03-27
KR20000070733A (ko) 2000-11-25
CN1154505C (zh) 2004-06-23
IL131007A0 (en) 2001-01-28
NO324452B1 (no) 2007-10-22
CZ295567B6 (cs) 2005-08-17
DE69829763D1 (de) 2005-05-19
NO993717D0 (no) 1999-07-30
ME00578A (en) 2011-12-20
ES2239799T3 (es) 2005-10-01
BR9807655A (pt) 2000-02-15
ZA98753B (en) 1998-08-05
JP2001509173A (ja) 2001-07-10
HUP0001014A3 (en) 2000-12-28
DE69829763T2 (de) 2006-04-13
PT1017408E (pt) 2005-07-29
HUP0001014A2 (hu) 2000-08-28
AU6616998A (en) 1998-08-26
US6147108A (en) 2000-11-14
KR100479968B1 (ko) 2005-03-30
RU2201272C2 (ru) 2003-03-27
ATE292975T1 (de) 2005-04-15
PL191222B1 (pl) 2006-03-31
HK1025251A1 (en) 2000-11-10
CA2278854A1 (en) 1998-08-13
WO1998034630A1 (en) 1998-08-13
EP1017408B1 (en) 2005-04-13
EP1017408A1 (en) 2000-07-12
ID22650A (id) 1999-12-02

Similar Documents

Publication Publication Date Title
NO993717L (no) Anvendelse av gastrointestinale lipase-inhibitorer
NO20004219L (no) Inhibitorer av fosfolipaseenzymer
NO20004220L (no) Inhibitorer av fosfolipaseenzymer
NO995802L (no) Anvendelse av oljelegemer
NO20004217D0 (no) Inhibitorer av fosfolipase A2
FI973596A0 (fi) Identifikation av talaktiviteten av en kaella
NO20000300D0 (no) Hydrogenolyse av glycerol
CY2014027I1 (el) Xρηση διαλκυλο φουμαρικων εστερων
NO20002639D0 (no) Inhibering av lipoproteinoksidering
DK0975778T3 (da) Anvendelse af glyphostat-resistende majslinier
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
PT927183E (pt) Inibidores espirociclicos de metaloproteases
NO20001979D0 (no) Anvendelse av inhibitorer av renin-angiotensin-systemet
NO20003256L (no) ACE inhibitor-MMP inhibitor kombinasjoner
PL337725A1 (en) Inhibitors of proteases
NO996545L (no) Behandling av aluminiumslagg
NO20012232D0 (no) Enzymatisk amidering av peptider
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
FI974508A (fi) Iskuja synnyttävä laite
ATE218809T1 (de) Kombination von enzymen
NO20000274D0 (no) Behandling av fluider
NO995269D0 (no) Anvendelse av immunmodulerende midler
ID20888A (id) Ragi pemetabolisasi organologam
NO983741D0 (no) Forankring av TLP-plattform

Legal Events

Date Code Title Description
MK1K Patent expired